Pillstats
Rx only · Tablet · Oral

Terbinafine Tablets 250 Mg

Terbinafine Hydrochloride

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)37801
US makers4 labelers
Packages7
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.040$0.080$0.119$0.159May 2026Jun 2026Jul 2026
$0.132
Latest avg · Jul 22, 2026
-4%
Since May 27, 2026
4
Active US suppliers
57%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/a244872952025 Q12025 Q22025 Q3
35
Rx · 2025 Q2
1.0K
Units dispensed
2
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Golden State Medical Supply, Inc.unknown2SUPPLYING
Cipla USA Inc.unknown2SUPPLYING
AMICI PHARMA INCunknown2SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.